Celle anti aging skin care has been named the ‘most innovative product’ of 2010Paris, France, October 18, 2010 — Biotivia, a world leading neutraceutical firm has been awarded the prestigious title of ‘most innovative product’ for their anti aging skin care product, Celle. The ceremony was held on Wednesday at the Pavillon Dauphine, in Paris, France. The award celebration was attended by over 300 of the pharmaceutical industry’s top manufacturers including Pfizer, Glaxo Smith Kline, Baxter Pharmaceuticals, DSM of Switzerland and many others.
Celle is the result of fours years of development and thousands of hours of testing and refinement by leading American, Italian and Swiss scientists to combine all natural active ingredients, backed by solid scientific evidence, in a uniquely effective new skin treatment to combat skin aging both internally and externally, and actually reverse much of the damage caused by years or decades of exposure to the sun, our challenging environment and a less than perfect diet. Celle was recognized as a true innovation in an “ethical, high performance skin treatment” whose effects compare with those of laser and chemical peels, Dermabrasion, Botox and other much more costly and uncomfortable procedures.
The unique formulation contains the so-called miracle molecule, resveratrol, four super fruit antioxidants, advanced hexapeptides, Japanese pearl extract, and Edelweiss plant progenitor cells. In Celle Biotivia has created a skin repair and rejuvenating cream that contains no harmful chemicals such as PEG’s, carbomers or parabens, still contained in other creams costing over $1000, while maintaining the texture, silkiness, and rich soft feel which these chemicals were thought to be essential for.
James Betz, founder and CEO of Biotivia, said: “This is a serious achievement and I am gratified that Celle has been given this recognition. It was enough just to be nominated for such a sought after award, but to go on and win the category is quite humbling. This award is testament to all the hard work and unique innovation that has gone into making Celle one of the most sought after skin treatments ever. We were up against some of the industry’s biggest players and our win proves that small innovative companies can develop a product that really works and gain industry recognition for its achievement.”
To read more about Celle and how it can help to combat anti aging then please visithttp://www.celleskincare.com/index_en.php
About Biotivia LLC
Biotivia was established in 1992 in Vienna, Austria as a supplier of natural raw materials and botanicals to the supplement and functional food industries and to researchers and scientific institutions worldwide. The company evolved into one of the world’s leading developers and suppliers of potent nutritional supplements and skin care therapies, with most of their products centered around the use of concentrated resveratrol and complementary botanical extracts.
Biotivia presently has US offices in New York, Los Angeles, Kansas City and international offices in the UK, Spain, Austria, Denmark, Italy, Germany, Singapore, Xi’an, China and Mumbai, India.
Beyond its strong consumer base, the company currently supplies researchers, physicians and scientists at Harvard, Stanford, Yale, Georgetown, The Albert Einstein Medical Center, University of Texas, M.D. Anderson Cancer Center and the University of California. Transmax and Bioforte in particular are being explored by several major universities as a possible treatment for a variety of conditions that seriously impair the health and well being of millions of people around the world. Biotivia recently signed an agreement to supply Transmax to the University of Ferrara for use in three human clinical trials in Italy and Egypt on its possible use by Thalassemia sufferers.
Biotivia’s resveratrol products, Transmax and Bioforte, have been independently assessed by Consumer Labs, the leading American quality watchdog, and were deemed both ‘most potent’ and ‘best value’.
Most of Biotivia’s other supplements have been certified Vegan by the American Vegetarian Association.
Neither Celle nor any Biotivia product has been shown to prevent any age related disease. Celle is not intended to diagnose, prevent, treat or cure any disease. The statements herein have not been reviewed or approved by the USFDA. All Biotivia supplements are manufactured in state of the art FDA inspected pharmaceutical facilities in accordance with CGMP USP standards.
Other press releases from Biotivia Bioceuticals LLC
- Anti-diabetic potential of resveratrol shown in study - September 2nd, 2011
- Biotivia Launch New Pterostilbene Supplement Called PteroActiv - August 23rd, 2011
- Resveratrol Could Benefit Type 2 Diabetics - August 23rd, 2011
- PteroActiv, the new pterostilbene supplement from Biotivia - August 16th, 2011
- Bowel Disorders Can Be Eased With Probiotic Supplements - August 16th, 2011
Contact InformationLeo Day
Title: Marketing Consultant
Biotivia Bioceuticals LLC